Mohamad Makhzoumi - Net Worth and Insider Trading
Mohamad Makhzoumi Net Worth
The estimated net worth of Mohamad Makhzoumi is at least $1.7 Billion dollars as of 2024-10-18. Mohamad Makhzoumi is the Director of Robinhood Markets Inc and owns about 23,829,279 shares of Robinhood Markets Inc (HOOD) stock worth over $642 Million. Mohamad Makhzoumi is the 10% Owner of Arcellx Inc and owns about 4,745,545 shares of Arcellx Inc (ACLX) stock worth over $455 Million. Mohamad Makhzoumi is also the 10% Owner of Mirum Pharmaceuticals Inc and owns about 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $167 Million. Besides these, Mohamad Makhzoumi also holds Savara Inc (SVRA) , MBX Biosciences Inc (MBX) , Korro Bio Inc (KRRO) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Trevi Therapeutics Inc (TRVI) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) . Details can be seen in Mohamad Makhzoumi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mohamad Makhzoumi has not made any transactions after 2024-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mohamad Makhzoumi
Mohamad Makhzoumi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mohamad Makhzoumi owns 33 companies in total, including Eargo Inc (EAR) , Metacrine Inc (MTCR) , and Inozyme Pharma Inc (INZY) among others .
Click here to see the complete history of Mohamad Makhzoumi’s form 4 insider trades.
Insider Ownership Summary of Mohamad Makhzoumi
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EAR | Eargo Inc | 2020-10-20 | 10 percent owner |
MTCR | Metacrine Inc | 2021-12-22 | 10 percent owner |
INZY | Inozyme Pharma Inc | 2020-07-28 | 10 percent owner |
2022-05-25 | 10 percent owner | ||
2020-07-23 | 10 percent owner | ||
2020-07-09 | 10 percent owner | ||
2020-06-30 | 10 percent owner | ||
2020-06-19 | 10 percent owner | ||
2022-04-11 | 10 percent owner | ||
2020-01-29 | 10 percent owner | ||
2020-12-04 | 10 percent owner | ||
2018-06-01 | 10 percent owner | ||
2019-07-22 | 10 percent owner | ||
2019-06-07 | 10 percent owner | ||
2018-12-07 | 10 percent owner | ||
2021-03-16 | 10 percent owner | ||
2018-06-01 | 10 percent owner | ||
2017-11-20 | 10 percent owner | ||
2023-07-17 | 10 percent owner | ||
2018-12-07 | 10 percent owner | ||
2021-04-08 | 10 percent owner | ||
2021-01-01 | 10 percent owner | ||
2021-06-24 | director & 10 percent owner | ||
2020-12-09 | 10 percent owner | ||
2022-05-03 | director & 10 percent owner | ||
2022-12-21 | 10 percent owner | ||
2021-07-21 | 10 percent owner | ||
2021-09-30 | 10 percent owner | ||
2021-06-23 | 10 percent owner | ||
2022-06-08 | 10 percent owner | ||
2018-01-19 | 10 percent owner | ||
2021-07-21 | 10 percent owner | ||
2024-04-22 | 10 percent owner |
Mohamad Makhzoumi Latest Holdings Summary
Mohamad Makhzoumi currently owns a total of 15 stocks. Among these stocks, Mohamad Makhzoumi owns 23,829,279 shares of Robinhood Markets Inc (HOOD) as of May 3, 2022, with a value of $642 Million and a weighting of 37.99%. Mohamad Makhzoumi owns 4,745,545 shares of Arcellx Inc (ACLX) as of December 21, 2022, with a value of $455 Million and a weighting of 26.88%. Mohamad Makhzoumi also owns 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) as of July 22, 2019, with a value of $167 Million and a weighting of 9.88%. The other 12 stocks Savara Inc (SVRA) , MBX Biosciences Inc (MBX) , Korro Bio Inc (KRRO) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Trevi Therapeutics Inc (TRVI) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) have a combined weighting of 25.26% among all his current holdings.
Latest Holdings of Mohamad Makhzoumi
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HOOD | Robinhood Markets Inc | 2022-05-03 | 23,829,279 | 26.96 | 642,437,362 |
ACLX | Arcellx Inc | 2022-12-21 | 4,745,545 | 95.78 | 454,528,300 |
MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 4,186,243 | 39.90 | 167,031,096 |
SVRA | Savara Inc | 2023-07-17 | 24,471,264 | 3.60 | 87,974,194 |
MBX | MBX Biosciences Inc | 2024-09-16 | 3,614,486 | 23.80 | 86,024,767 |
KRRO | Korro Bio Inc | 2024-04-22 | 1,090,793 | 76.73 | 83,696,547 |
AVEO | AVEO Pharmaceuticals Inc | 2020-06-19 | 3,952,958 | 15.00 | 59,294,370 |
AKUS | Akouos Inc | 2020-06-30 | 4,294,207 | 13.29 | 57,070,011 |
TRVI | Trevi Therapeutics Inc | 2022-04-11 | 11,370,376 | 3.07 | 34,907,054 |
INZY | Inozyme Pharma Inc | 2020-07-28 | 2,437,689 | 5.27 | 12,846,621 |
MRKR | Marker Therapeutics Inc | 2021-03-16 | 1,071,429 | 3.33 | 3,567,859 |
RGLS | Regulus Therapeutics Inc | 2020-12-04 | 645,106 | 1.58 | 1,016,042 |
EAR | Eargo Inc | 2020-10-20 | 326,001 | 2.57 | 837,823 |
MTCR | Metacrine Inc | 2021-12-22 | 2,563,257 | 0.00 | 3,589 |
GNCAQ | Genocea Biosciences Inc | 2022-05-25 | 0 | 0.00 | 0 |
Holding Weightings of Mohamad Makhzoumi
Mohamad Makhzoumi Form 4 Trading Tracker
According to the SEC Form 4 filings, Mohamad Makhzoumi has made a total of 2 transactions in Robinhood Markets Inc (HOOD) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Robinhood Markets Inc is the sale of 1,952 shares on May 3, 2022, which brought Mohamad Makhzoumi around $19,637.
According to the SEC Form 4 filings, Mohamad Makhzoumi has made a total of 1 transactions in Arcellx Inc (ACLX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Arcellx Inc is the sale of 179 shares on December 21, 2022, which brought Mohamad Makhzoumi around $5,502.
According to the SEC Form 4 filings, Mohamad Makhzoumi has made a total of 0 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 450,000 shares on July 22, 2019, which cost Mohamad Makhzoumi around $7 Million.
More details on Mohamad Makhzoumi's insider transactions can be found in the Insider Trading History of Mohamad Makhzoumi table.Insider Trading History of Mohamad Makhzoumi
- 1
Mohamad Makhzoumi Trading Performance
GuruFocus tracks the stock performance after each of Mohamad Makhzoumi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mohamad Makhzoumi is -11.41%. GuruFocus also compares Mohamad Makhzoumi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mohamad Makhzoumi within 3 months outperforms 10 times out of 26 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mohamad Makhzoumi's insider trading performs compared to the benchmark.
Performance of Mohamad Makhzoumi
Mohamad Makhzoumi Ownership Network
Mohamad Makhzoumi Owned Company Details
What does Eargo Inc do?
Who are the key executives at Eargo Inc?
Mohamad Makhzoumi is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .
Eargo Inc (EAR) Insider Trades Summary
Over the past 18 months, Mohamad Makhzoumi made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 1,528 shares made by William Brownie , a net sale of 38 shares made by Adam Laponis , and a net sale of 6 shares made by Mark Thorpe .
In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,630 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,630 shares.
Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eargo Inc Insider Transactions
Mohamad Makhzoumi Mailing Address
Above is the net worth, insider trading, and ownership report for Mohamad Makhzoumi. You might contact Mohamad Makhzoumi via mailing address: 2855 Sand Hill Road, Menlo Park Ca 94025.